Results
|
|
1.
|
Preconception maternal lipoprotein levels in relation to fecundability. MedStar authors:
Year: 2017
Citation: - Human Reproduction. 32(5):1055-1063, 2017 May 01
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Maternal-Fetal Medicine
Medline publication type:
- Journal Article
- Randomized Controlled Trial
All authors: - Browne RW, Grantz KL, Lynch AM, Mumford SL, Perkins NJ, Pugh SJ, Schisterman EF, Silver R, Sjaarda L, Stanford JB, Wactawski-Wende J, Wilcox B
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
Accuracy of sonographic chorionicity classification in twin gestations. MedStar authors:
Year: 2014
Citation: - Journal of Ultrasound in Medicine. 33(12):2187-92, 2014 Dec.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology, Maternal-Fetal Medicine
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Blumenfeld YJ, Caritis SN, Carpenter MW, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Harper M, Iams JD, Lo J, Malone FD, Mercer BM, Momirova V, Peaceman AM, Ramin SM, Reddy UM, Rouse DJ, Sciscione A, Sorokin Y, Thorp JM Jr, Varner MW
|
|
|
5.
|
Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT). MedStar authors:
Year: 2016
Citation: - American Journal of Cardiology. 118(9):1399-1404, 2016 Nov 01
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ballantyne CM, Brunner G, Chen C, Kamran H, Kougias P, Lumsden AB, Morrisett JD, Nambi V, Negi S, Virani SS, Yang EY
|
|
|
6.
|
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors:
Year: 2012
Citation: - Lancet Oncology. 13(7):734-42, 2012 Jul.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P
|
|
|
7.
|
|
|
|
8.
|
Three-year outcomes of vaginal mesh for prolapse: a randomized controlled trial. MedStar authors:
- Gutman, Robert E
- Iglesia, Cheryl B
- Peterson, Joanna L
- Sokol, Andrew I
- Wang, Hong
Citation: - Obstetrics & Gynecology. 122(4):770-7, 2013 Oct.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Gutman RE, Iglesia CB, Nosti PA, Peterson JL, Sokol AI, Sokol ER, Wang H
|
|
|
9.
|
NuMoM2b Sleep-Disordered Breathing study: objectives and methods. MedStar authors:
Year: 2015
Citation: - American Journal of Obstetrics & Gynecology. 212(4):542.e1-127, 2015 Apr.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology, Maternal-Fetal Medicine
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, N.I.H., Extramural
All authors: - Basner RC, Chung JH, Facco FL, Grobman WA, Haas DM, Koch MA, Louis JM, Mercer BM, Mobley DR, Nhan-Chang CL, Parker CB, Parry S, Pien GW, Reddy UM, Redline S, Saade GR, Schubert FP, Silver RM, Simhan HN, Wing DA, Zee PC
|
|
|
10.
|
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. MedStar authors:
Year: 2016
Citation: - American Journal of Cardiovascular Drugs. 16(1):55-65, 2016 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Ballantyne CM, Barter PJ, Borgman M, Brewer HB, Herrman JP, Hu B, Kastelein JJ, Kataoka Y, Merkely B, Nicholls SJ, Nissen SE, Puri R, Uno K, Wolski K
|
|
|
11.
|
|
|
|
12.
|
Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Year: 2013
Citation: - Journal of Obstetrics & Gynaecology. 33(6):557-60, 2013 Aug.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Caritis S, Clark S, Feghali MN, Hankins G, Koren G, Matok I, Mattison DR, Miodovnik M, Nordeng H, Umans J
|
|
|
13.
|
Early Outpatient Treatment for Covid-19 with Convalescent Plasma. MedStar authors:
Year: 2022
Citation: - New England Journal of Medicine. 386(18):1700-1711, 2022 05 05.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Abinante M, Anjan S, Appel LJ, Baksh SN, Blair JE, Bloch EM, Broderick PB, Cachay ER, Casadevall A, Cluzet VC, Cordisco ME, Cruser D, Currier JS, Ehrhardt S, Ford DE, Forthal DN, Foster EC, Fukuta Y, Gawad AL, Gebo KA, Gerber JM, Gniadek TJ, Greenblatt B, Hammel J, Hammitt LL, Hanley DF, Heath SL, Huaman MA, Jabs DA, Karlen N, Kassaye SG, Klein SL, Laeyendecker O, Lane K, Lau B, Levine AC, Marshall CE, McBee NA, Meisenberg BR, Mosnaim GS, Oei K, Patel B, Paxton JH, Pekosz A, Petrini JR, Rausch W, Raval JS, Roth M, Shade DM, Shenoy AG, Shoham S, Singh A, Spivak ES, Sullivan DJ, Sutcliffe CG, Tobian AAR, Yarava A, Zand MS
|
|
|
14.
|
|
|
|
15.
|
Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial. MedStar authors:
Year: 2013
Citation: - Journal of the Academy of Nutrition & Dietetics. 113(10):1302-10, 2013 Oct.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Carbone L, Chlebowski RT, Eaton C, Johnson KC, Kooperberg CL, Lu B, Mossavar-Rahmani Y, Pettinger M, Stefanick M, Wactawski-Wende J, Walitt B, Wallace R, Womack C
|
|
|
16.
|
|
|
|
17.
|
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. MedStar authors:
Year: 2021
Citation: - Nature Medicine. 27(10):1818-1824, 2021 10.
Department: - MedStar Heart and Vascular Institute
Medline publication type:
All authors: - Axelsson A, Bach RG, Becker JR, Benson L, Braunwald , Bundgaard H, Burns KM, Canter C, Cirino AL, Colan SD, Day SM, Ho CY, Lakdawala NK, Lever HM, MacRae CA, Margossian R, McMurray JJV, Mestroni L, Murphy AM, Orav EJ, Owens AT, Patel AR, Pereira AC, Rossano JW, Russell MW, Seidman CE, Solomon SD, Soslow JH, Taylor MRG, Thrush P, VANISH Investigators, Vargas JD, Wheeler MT, Wilmot I, Zahka K
|
|
|
18.
|
|
|
|
19.
|
Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience. MedStar authors:
Year: 2019
Citation: - Clinical Trials. 16(3):306-315, 2019 06.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Brodsky IG, Chadha C, Chatterjee R, D2d Research Group, Desouza C, LeBlanc ES, Ouellette MG, Phillips LS, Pittas AG, Sheehan PR, Staten MA, Vickery EM
|
|
|
20.
|
|
|
|
21.
|
|
|
|
22.
|
Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease. MedStar authors:
Year: 2019
Citation: - Menopause. 26(8):841-849, 2019 08.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aragaki AK, Cauley J, Howard B, Jiang X, Johnson KC, Kelsey AM, LeBlanc ES, Manson JE, Martin LW, Nudy M, O'Sullivan DM, Payne ME, Robbins JA, Schnatz PF, Shikany JM, Stefanick ML
|
|
|
23.
|
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(9):1724-1732, 2019 09.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Altuntas Y, Aroda VR, Christiansen E, Haluzik M, Hertz CL, Jeppesen OK, Lalic NM, Morales Villegas EC, PIONEER 1 Investigators, Rosenstock J, Terauchi Y
|
|
|
24.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
|
25.
|
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design. MedStar authors:
Year: 2016
Citation: - American Heart Journal. 177:66-73, 2016 Jul
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alvaro G, Amantea B, Auci E, Auriemma S, Baiocchi M, Bianchi A, Biondi-Zoccai G, Bove T, Bradic N, Buscaglia G, Calabro MG, Cariello C, Corcione A, De Vuono G, Fominskiy E, Frontini M, Galdieri N, Gemma M, Gianni S, Grigoryev E, Guarracino F, Landoni G, Lembo R, Likhvantsev V, Lipinski MJ, Lobreglio R, Lomivorotov VV, Monaco F, Pala G, Paternoster G, Pisano A, Sangalli F, Wang CY, Zangrillo A, Zucchetti MC
|
|
|
26.
|
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial. MedStar authors:
Year: 2023
Citation: - JAMA. 330(22):2171-2181, 2023 12 12.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comment
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Mehra MR, Netuka I, Uriel N, Katz JN, Pagani FD, Jorde UP, Gustafsson F, Connors JM, Ivak P, Cowger J, Ransom J, Bansal A, Takeda K, Agarwal R, Byku M, Givertz MM, Bitar A, Hall S, Zimpfer D, Vega JD, Kanwar MK, Saeed O, Goldstein DJ, Cogswell R, Sheikh FH, Danter M, Pya Y, Phancao A, Henderson J, Crandall DL, Sundareswaran K, Soltesz E, Estep JD
|
|
|
27.
|
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(12):2262-2271, 2019 12.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
|
|
|
28.
|
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
Year: 2014
Citation: - Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
|
|
|
29.
|
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study. MedStar authors:
- Shara, Nawar M
- Wang, Hong
Year: 2014
Citation: - Inflammatory Bowel Diseases. 20(5):872-81, 2014 May.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Hanauer S, Harris MS, Reinisch W, Shara N, Travis S, Wang H
|
|
|
30.
|
Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury. MedStar authors:
- Jordan, Marion H
- Shupp, Jeffrey W
Year: 2015
Citation: - Clinical Journal of Pain. 31(1):21-9, 2015 Jan.
Institution: - MedStar Washington Hospital Center
All authors: - Bangdiwala SI, Bortsov AV, Cairns BA, Haith LR, Halawa OI, Holmes JH, Hoskins JM, Hwang J, Jones SW, Jordan MH, McLean SA, Orrey DC, Platts-Mills TF, Roane BR, Shupp JW
|
|
|
31.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
|
32.
|
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. MedStar authors:
Year: 2021
Citation: - The Lancet Infectious Diseases. 21(2):213-225, 2021 02.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Matsunaga Y, Menon A, Nagata TD, Pogue JM, Shorr AF, Timsit JF, Wunderink RG, Zeitlinger M
|
|
|
33.
|
Baseline Characteristics of the VANISH Cohort. MedStar authors:
Year: 2019
Citation: - Circulation: Heart Failure. 12(12):e006231, 2019 12.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Axelsson Raja A, Bach R, Becker J, Benson L, Braunwald E, Bundgaard H, Canter C, Choudhury L, Cirino AL, Colan SD, Day SM, Hall EK, Ho CY, Jefferies JL, Lever H, Lewis GD, Lin KY, MacRae CA, Margossian R, McMurray JJV, Mestroni L, Murphy AM, Orav EJ, Owens AT, Pahl E, Patel AR, Pereira AC, Rossano J, Russell M, Shi L, Solomon SD, Taylor M, Vargas JD, Wheeler MT, Zahka K
|
|
|
34.
|
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction. MedStar authors:
Year: 2020
Citation: - Journal of the American Heart Association. 9(5):e014941, 2020 03 03.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abbate A, Abouzaki N, Appleton D, Biondi-Zoccai GG, Bressi E, Buckley LF, Canada JM, Carbone S, Chiabrando JG, Christopher S, Del Buono MG, Dixon DL, Garnett J, Kadariya D, Kontos MC, Lipinski MJ, Markley R, Medina de Chazal H, Melchior R, Mueller G, Puckett L, Roberts CS, Schatz A, Thomas C, Trankle CR, Turlington J, Van Tassell BW, Vo C, Wohlford GF
|
|
|
35.
|
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. MedStar authors:
- Dooley, Daniel J
- Lam, Phillip H
Year: 2018
Citation: - European Journal of Heart Failure. 20(2):359-369, 2018 02.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Aban IB, Adamopoulos C, Ahmed A, Allman RM, Anker SD, Aronow WS, Arundel C, Bhatt DL, Blackman MR, Butler J, Deedwania P, Dooley DJ, Filippatos GS, Fletcher RD, Fonarow GC, Forman DE, Kanonidis IE, Lam PH, Patel K, Pitt B, White M
|
|
|
36.
|
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. MedStar authors:
Year: 2014
Citation: - Critical Care (London, England). 18(4):R157, 2014.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
All authors: - Charbonneau C, Chastre J, Gao X, Nathwani D, Niederman M, Patel DA, Shorr AF, Simor A, Stephens JM
|
|
|
37.
|
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
Year: 2013
Citation: - Oncologist. 18(3):257-64, 2013.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
|
|
|
38.
|
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. MedStar authors:
Year: 2019
Citation: - Lancet Oncology. 20(1):88-99, 2019 01.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE Jr, Graham ML, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Paik S, Rastogi P, Seay TE, Soori GS, Swain SM, Wade JL 3rd, Walshe JM, Wickerham DL, Wolmark N
|
|
|
39.
|
|
|
|
40.
|
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. MedStar authors:
Year: 2014
Citation: - Journal of Rheumatology. 41(2):300-9, 2014 Feb.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Chatham WW, Freimuth WW, Furie RA, Ginzler EM, LBSL02/99 Study Group, McCune WJ, McKay JD, Merrill JT, Petri MA, Stohl W, Wallace DJ, Weinstein A, Zhong ZJ
|
|
|
41.
|
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. MedStar authors:
Year: 2015
Citation: - Journal of the American College of Cardiology. 66(20):2201-10, 2015 Nov 17.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Adelman SJ, Brewer HB, Kane JP, Krueger KA, Nicholls SJ, Nissen SE, Rader DJ, Ruotolo G, Wang MD
|
|
|
42.
|
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial. MedStar authors:
Year: 2017
Citation: - Obstetrics & Gynecology. 129(1):121-129, 2017 Jan
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
All authors: - Aragaki AK, Cauley JA, Howard BV, Jiang X, Johnson KC, LeBlanc ES, Manson JE, Martin LW, Nudy M, O'Sullivan DM, Payne ME, Robbins J, Schnatz PF, Shikany JM, Stefanick ML, Williams M
|
|
|
43.
|
Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Citation: - Journal of Clinical Pharmacology. 53(3):334-8, 2013 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Caritis S, Clark S, Hankins G, Koren G, Matok I, Miodovnik M, Umans J
|
|
|
44.
|
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
45.
|
|
|
|
46.
|
Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. MedStar authors:
Year: 2016
Citation: - Journal of the National Cancer Institute. 108(3), 2016 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Anderson GL, Aragaki AK, Chen C, Chlebowski RT, Haque R, Howard BV, Manson JE, Reed SD, Rohan TE, Runowicz CD, Sarto GE, Simon MS, Thomson CA, Wactawski-Wende J
|
|
|
47.
|
|
|
|
48.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
49.
|
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors:
Year: 2015
Citation: - Lancet. 386(9992):452-60, 2015 Aug 1.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ
|
|
|
50.
|
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors:
Year: 2016
Citation: - Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J
|
|
|
51.
|
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease. MedStar authors:
Year: 2017
Citation: - Journal of Alzheimer's Disease. 55(3):1039-1053, 2017
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Randomized Controlled Trial
All authors: - Alexander RC, Cebers G, Eketjall S, Ereshefsky L, Goldwater R, Haeberlein SB, Han D, Kugler AR, Maltby J, Olsson T, Rosen L, Russell M, Ye N
|
|
|
52.
|
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. MedStar authors:
Year: 2017
Citation: - New England Journal of Medicine. 376(20):1933-1942, 2017 05 18
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - ACCELERATE Investigators, Barter PJ, Brewer HB, Conde D, Fox KAA, Gibson CM, Goodman SG, Granger C, Kandath D, Kouz S, Leiva-Pons JL, Li W, Lincoff AM, Mason D, McErlean E, McGuire DK, Menon V, Montalescot G, Nicholls SJ, Nicolau JC, Nissen SE, Pesant Y, Rader D, Riesmeyer JS, Ruotolo G, Tahirkheli N, Tall AR, Vangerow B, Weerakkody G, Wolski K
|
|
|
53.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
|
54.
|
A randomized pilot study on the effect of niacin on pulmonary arterial pressure. MedStar authors:
- Dooley, Daniel J
- McNamara, Martin J
- Sayanlar, Jason J
- Srichai, Monvadi B
- Taylor, Allen J
Year: 2015
Citation: - Trials [Electronic Resource]. 16:530, 2015.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Dooley DJ, McNamara MJ, Sayanlar JJ, Srichai MB, Taylor AJ
|
|
|
55.
|
|
|
|
56.
|
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
- Fatemi, Omid
- Yuriditsky, Eugene
Citation: - American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
|
|
|
57.
|
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors:
Year: 2018
Citation: - New England Journal of Medicine. 379(12):1107-1117, 2018 09 20.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD
|
|
|
58.
|
|
|
|
59.
|
|
|
|
60.
|
Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Year: 2015
Citation: - BMC Pregnancy & Childbirth. 15:59, 2015.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Caritis SN, Clark S, Hankins GD, Koren G, Matok I, Mattison DR, Miodovnik M, Umans JG
|
|
|
61.
|
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease. MedStar authors:
Year: 2019
Citation: - Pharmacology Research & Perspectives. 7(2):e00470, 2019 04.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Ahn J, Arellano J, Fowler AJ, Hebron ML, Howard HH, Lawler A, Liu X, Matar S, Moussa C, Mundel EE, Pagan FL, Peyton M, Schwartz SL, Starr NJ, Torres-Yaghi Y, Wilmarth B, Yusuf N
|
|
|
62.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|
|
|
63.
|
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors:
Year: 2012
Citation: - The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW
|
|
|
64.
|
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. MedStar authors:
Year: 2015
Citation: - Clinical Infectious Diseases. 61 Suppl 2:S87-93, 2015 Sep 15.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Barriere SL, Corey GR, Hardin TC, Lacy MK, Luke DR, Nogid B, Shorr AF, Stryjewski ME, Wang W
|
|
|
65.
|
Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors:
Year: 2017
Citation: - Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP
|
|
|
66.
|
|
